Engage Bio

Engage Bio is a biotechnology company focused on developing innovative cancer therapies. The company specializes in creating mRNA drugs that induce cancer cells to produce locally acting immunotherapies. These therapies are designed to engage the patient's immune system and redirect it to target and destroy cancer cells. Engage Bio operates in the oncology market and primarily serves patients diagnosed with various types of cancer. The company's business model revolves around research and development, clinical trials, and eventual commercialization of their proprietary therapies. Revenue is generated through partnerships with pharmaceutical companies, licensing agreements, and potential future sales of approved therapies.

Keywords: biotechnology, mRNA drugs, cancer therapy, immunotherapy, oncology, immune system, cancer cells, clinical trials, pharmaceutical partnerships, Santa Clara